Posts

November 05, 2014

+
2:47 PM | Video Tip of the Week: Genome Browser in a Box
We’ve been doing UCSC Genome Browser training workshops for a decade now. We’ve seen all sorts of situations–from places that had terrific bioinformatics and IT support, to places where the attendees had no idea if anyone provided support at their institution. Ironically, sometimes the places with little support were big-name research places where all the […]

Haeussler M., B. J. Raney, A. S. Hinrichs, H. Clawson, A. S. Zweig, D. Karolchik, J. Casper, M. L. Speir, D. Haussler & W. J. Kent & (2014). Navigating protected genomics data with UCSC Genome Browser in a Box, Bioinformatics, DOI: http://dx.doi.org/10.1093/bioinformatics/btu712

Citation
+
2:37 PM | Tips and Tricks for Successful Nucleic Acid Preparation from FFPE Samples: Webinar Preview
Formalin-fixed, paraffin-embedded (FFPE) tissue samples are extremely common sample types. In this form, tissue is easy to store for extremely long periods of time and useful for immunohistochemical studies. Additionally FFPE samples are fairly inexpensive to produce. However the formalin fixation procedure, which was developed long before the advent of molecular biology, results in chemical […]
+
2:30 PM | Astellas EMEA CEO volunteers at school
Ken Jones promotes healthy lifestyle as part of Changing Tomorrow campaign
+
11:33 AM | Amgen's trebananib misses survival target in ovarian cancer
First phase III trial improved survival rates by just one month
+
10:53 AM | Merck KGaA’s Oschmann elected president of IFPMA
He takes over from Lilly’s John Lechleiter
+
10:25 AM | Roche invests in diagnostics in China
Commits 450m Swiss francs to manufacturing facility
+
8:30 AM | Lundbeck still feeling effects from Cipralex patent loss
The antidepressant sales dropped another 33% in the third quarter
+
12:16 AM | Successful partnerships in pharma: Skyepharma and Mundipharma
Why skills and flexibility matter more than sheer size
+
12:16 AM | Former Vodafone UK comms head joins ABPI
Aileen Thompson appointed director of communications at UK pharma trade body
+
12:15 AM | LabCorp to acquire Covance for $5.6bn
Combines diagnostics expertise with contract research

November 04, 2014

+
8:23 PM | Automated Droplet Generator System Tour
Tweet This Post
+
6:32 PM | Election Day Open Thread
Today is Election Day, and people across the United States will be casting their votes in various political races, deciding the fates of politicians and ballot measures alike. This year, there are quite a few local issues related to genetically…Read more ›
+
2:16 PM | Actavis considering Allergan acquisition, says report
Wall Street Journal says Irish pharma company set to compete with Valeant bid
+
1:30 PM | Cell Therapy Commercialization: A View from GE Healthcare on Immunotherapy
. Those following the regenerative medicine (RM) industry are likely in-tune with a rapidly evolving market, on the periphery, that is shaping up to provide a very attractive value proposition to patients, industry, and investors alike. The health care industry is undergoing a paradigm shift: Big Pharma has historically spread its efforts across palliative and substitutive...Read more
+
11:08 AM | AZ advances immuno-oncology ambitions
Buys imaging company and signs PD-1 collaborations with Pharmacyclics and J&J
+
11:03 AM | BMS takes option to buy fibrosis firm Galecto
The Swedish biotech has a pulmonary fibrosis candidate in early-stage testing
+
10:19 AM | Astellas earmarks up to $1.2bn for protein folding research
Teams up with US company to investigate diseases caused by protein defects
+
3:05 AM | Biotech Reading List
The 100 most highly cited papers of all time: Tools, not ideasAsh Jogalekar (The Curious Wavefunction)Selling Imported Medicines in Maine, Mostly Viagra: O’Brien ExplainsEd Silverman (Pharmalot / WSJ)High Drug Prices Could Increase Industry InnovationJohn LaMattina (Forbes)Secret of healthy ageing discovered in ground-breaking 35-year studyThe Telegraph (UK)There Is No ‘Healthy’ MicrobiomeEd Yong (New York Times)A plutocratic proposal: If mega-rich people could buy places […]
+
12:16 AM | Novo Nordisk’s Klaus Henning Jensen on trends in medical affairs
PMLiVE speaks to the head of clinical, medical and regulatory for Novo in the UK and Ireland
+
12:16 AM | Former NICE chair Sir Michael Rawlins to lead MHRA
He will take up his new role at the UK's medicines and devices regulator in December
+
12:16 AM | Publicis Groupe to acquire Sapient for $3.7bn
Merger comes just months after Publicis’ failed acquisition of Omnicom
+
12:16 AM | Horizon Discovery appoints executive director
David Smoller is chief business officer at the genomics firm
+
12:15 AM | NICE backs GSK drug for leukaemia
Arzerra on course for NHS use in blood cancer

November 03, 2014

+
10:27 PM | Nose Cells Help Paralyzed Man Walk Once Again
Scientists at UCL have performed a groundbreaking procedure which utilizes specialized nose cells, otherwise known ass Olfactory Ensheathing Cells (OEC), to restore function to the legs of a man who was previously paralyzed in a knife attack. The procedure involves removing the olfactory bulb from the brain of the recipient and subsequently growing the OEC […]
+
10:15 PM | Not all scientific articles are equal in science
In evaluating a scientific claim made by anyone, the only thing that matters is the quality and quantity of evidence. It does matter who is making the claim, it does not matter if you believe their claim, and it does not matter if they make a powerful emotional argument–absent real evidence, it is nothing but […]Continue reading «Not all scientific articles are equal in science»
+
5:26 PM | Biotechnology Youth Apprenticeship Program Fosters Young Scientists
Ellyn Lepinski is an intern at Promega who started her biotechnology career path five years ago as a high school junior taking a course from the BTC Institute (www.btci.org) as part of the Biotechnology Youth Apprenticeship Program. Ellyn credits the program with helping her achieve her goals: “Over the course of two years in which […]
+
11:48 AM | EMA starts review of Biogen Idec's haemophilia A therapy
Elocta already on the market in the US, Canada and Australia
+
11:34 AM | AbbVie is not looking at another big acquisition, says CEO
Unlikely to consider another deal on the scale of failed Shire merger
+
11:34 AM | Bayer completes takeover of Chinese OTC company
Expands consumer health presence with Dihon purchase
+
8:09 AM | Using light to move objects
Moving objects using light beams is a very popular science fiction idea that has been around since at least the early 1900s. In the 1980s, this fiction became reality on the microscopic scale with the invention of optical tweezers. Optical tweezers are focused lasers that can control movement of microscopic objects, from atoms up to […]
23456789
262 Results